Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
The EP Device Registry is a clinical trial studying the safety and effectiveness of Abbott's electrophysiology devices, which are used to diagnose and treat heart rhythm disorders. The goal of this study is to gather ongoing, high-quality information about how well these devices work in real-life situations, outside of a controlled clinical environment.
To participate in this trial, you need to have had a specific heart imaging or treatment procedure using one of Abbott's devices. It's also important that you're able to follow up with your healthcare team as recommended. If you're currently involved in another clinical study that might affect the results of this registry, you won't be eligible to participate. If you join, you can expect to provide information about your experience with the device over time, helping researchers understand its benefits and safety in everyday use.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subject underwent an electrophysiology imaging (diagnostic procedure) and/or ablation procedure that used one or more Abbott devices covered by this Registry.
- • Subject is willing and able to comply with the site's standard of care follow-up schedule.
- Exclusion Criteria:
- • Subject is currently participating in another clinical investigation that may confound the results of this Registry.
About Abbott Medical Devices
Abbott Medical Devices is a leading global healthcare company dedicated to advancing medical technology through innovative research and development. With a robust portfolio of diagnostic, therapeutic, and monitoring solutions, Abbott is committed to improving patient outcomes and enhancing the quality of care across various medical fields. The company places a strong emphasis on clinical trials to validate the safety and efficacy of its products, ensuring compliance with regulatory standards and fostering collaboration with healthcare professionals. By leveraging cutting-edge science and technology, Abbott Medical Devices aims to address pressing health challenges and deliver transformative solutions that empower patients and healthcare providers alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pisa, , Italy
Lisboa, , Portugal
Budapest, , Hungary
Carnaxide, , Portugal
Chandigarh, , India
Mestre, Veneto, Italy
Porto, , Portugal
Milano, Lombard, Italy
New Delhi, , India
Leeuwarden, Friesland, Netherlands
München, Bavaria, Germany
Linz, Upr Aus, Austria
Wiener Neustadt, Lower Austria, Austria
Brno, Moravia Silesia, Czechia
Clermont Ferrand, Auvergne, France
Ollioules, Provence Alpes Azur, France
Avignon, Provence Alpes Côte D'azur, France
Köln, North Rhine Westphalia, Germany
Trivandrum, , India
Roma, Rome, Italy
Nieuwegein, Utrecht Canada, Netherlands
Den Haag, Zuid Holland, Netherlands
Huelva, Andalusia, Spain
Pamplona, Navarre, Spain
Dresde, , Germany
Vellore, Tmlnadu, India
Barcelona, Catalon, Spain
Avignon, Provence, France
Patients applied
Trial Officials
Anne Sarver, PhD
Study Director
Abbott
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials